Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 11 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

daratumumab 3 Dexamethasone 3 Bortezomib 2 sodium thiosulfate 1 pomalidomide 1 pembrolizumab 1 etoposide phosphate 1 darlin protein, Dictyostelium 1 bosutinib 1 Thalidomide 1 Restraint, Physical 1 Pemetrexed 1 Mitoxantrone 1 Lenalidomide 1 Gemtuzumab 1 Etoposide 1 Daunorubicin 1 Cytarabine 1 Crizotinib 1 Cisplatin 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Has announcements × Lenalidomide × Clear all

NCT03710603 2026-02-10

Perseus

European Myeloma Network B.V.

Phase 3 Active not recruiting

709 enrolled 17 charts 1 FDA

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡